The National Prostate Cancer Register in Sweden 1998—2002: Trends in incidence, treatment and survival

References

• Parkin DM, Bray Fl, Devessa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001;37(Suppl):4–66.
   Google Scholar
• Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate specific antigen screening: lessons from U.S. prostate cancer inci-dence trends. J Natl Cancer Inst 2002;94:981–90.
   Google Scholar
• Ransohoff DF, McNaughton Cillins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002;113:663 —7.
   PubMed Web of Science ®Google Scholar
• Damber JE. Decreasing mortality rates for prostate cancer: possible role of hormonal therapy. BJU Int 2004;93:695–701.
   PubMed Web of Science ®Google Scholar
• Mettlin CJ, Murphy T, Rosenthal DS, Menck HR. The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S. Cancer 1998;83: 1679–84.
   PubMed Web of Science ®Google Scholar
• Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the Surveillance, Epidemiology and End Results program data: recent trends in cancer mortality rates. J Natl Cancer Inst 1992;84:872–7.
   Google Scholar
• National Center for Health Statistics. The person number system of Sweden, Norway, Denmark and Israel. In: Lunde AS, editor. Vital and health statistics, Series 2, No. 84. Washington D.C.: Government Printing Office, 1980. DHHS 80–1358.
   Google Scholar
• Mattsson B. The completeness of registration in the Swedish Cancer Registry, Report No. 15. Stockholm, Sweden: Stat Rep HS; 1977.
   Google Scholar
• Socialstyrelsen. Cancer incidence in Sweden 2002. Available from: www.sos.se
   Google Scholar
• Sandblom G, Dufmats M, Nordenskjöld K, Varenhorst E. Prostate cancer trends in three counties in Sweden 1987–1996. Results from a population-based register. Cancer 2001;88: 1445–53.
   Google Scholar
• Sandblom G, Dufmats M, Olsson M, Varenhorst E. Validity of a population-based cancer register in Sweden. An assess-ment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol 2003; 37:112–9.
   Google Scholar
• Sennfalt K, Carlsson P, Thorfinn J, Frisk J, Henriksson M, Varenhorst E. Technological changes in the management of prostate cancer result in increased healthcare costs. Scand J Urol Nephrol 2003;37:226–31.
   PubMed Web of Science ®Google Scholar
• Sandblom G, Carlsson P, Sennfdlt K, Varenhorst E. A population-based study of pain and quality of life during the year before death in men with prostate cancer. Br J Cancer 2004;90:1163–8.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002. p. 184–7.
   Google Scholar
• Sandblom G, Holmberg L, Damber JE, Hugosson J, Johansson JE, Lundgren R, et al. Prostate-specific antigen for prostate cancer staging in a population based register. Scand J Urol Nephrol 2001;36:99–105.
   Google Scholar
• Egevad L. Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology 2001;57:291–5.
   PubMed Web of Science ®Google Scholar
• Kvalitetsregister. Prostatacancer Primärregistrering 1998–2002 (Figures and Tables in English). Available from: www.roc.se
   Google Scholar
• Management program—prostate cancer (in Swedish). Avail-able from: www.sos.se/marsirkt026.htm
   Google Scholar
• Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of cancer patient survival. Eur J Cancer 2002;38:690–5.
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6:101–21.
   Google Scholar
• Parkin DM, Hakulinen T. Analysis of survival. IARC Sci Publ 1991;95:159–76.
   Google Scholar
• Moller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prey 2002;11:1–96.
   PubMed Web of Science ®Google Scholar
• Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff JM, et al. EAU guidelines on prostate cancer. Eur Urol 2001;40:97–101.
   PubMed Web of Science ®Google Scholar